Elevated Financial Group’s Oracle ORCL Stock Holding History

Elevated Financial Group’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,439	Closed	-$280K	–	138
2025 Q4	$280K	Buy	+1,439	New	+$343K	0.1%	111

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Elevated Financial Group's ORCL Position: Q1 2026 in Review

Elevated Financial Group sold out of Oracle (ORCL) in Q1 2026, closing a stake of 1,439 shares — an estimated $280K sold.

Elevated Financial Group first reported a position in ORCL in Q4 2025 and held it in 1 quarter. The position peaked at $280K in Q4 2025. 3,494 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

Elevated Financial Group reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
Elevated Financial Group sold 1,439 Oracle shares in Q1 2026, an estimated $280K.
Elevated Financial Group first reported a position in Oracle in Q4 2025 and held it in 1 quarter.
Elevated Financial Group's Oracle position peaked at $280K in Q4 2025.
3,494 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Elevated Financial Group's 13F filing for Q1 2026, filed 11 May 2026.